Neumora Therapeutics, Inc. Common Stock (NMRA) NASDAQ
1.76
+0.015(+0.86%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.76
+0.015(+0.86%)
Currency In USD
| Market Cap | 292.47M |
| Enterprise Value | 110.42M |
| P/E Ratio | -1.42 |
| PEG Ratio | -0.07 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 4.47 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.81 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.45 |
| Return On Equity | -1.82 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -5M |
| EBITDA | -233.37M |
| Net Income | -236.93M |
| Diluted EPS | -1.45 |
| Total Cash | 147.07M |
| Total Cash/Share | 0.82 |
| Total Debt | 410,000 |
| Total Debt/Equity | 0.01 |
| Current Ratio | 5.09 |
| Book Value Per Share | 0.39 |
| 52-Week Change | 122.15 |
| 52-Week High | 3.65 |
| 52-Week Low | 0.72 |
| Moving Average 50 Days | 2.06 |
| Moving Average 200 Days | 2.2 |
| Average Volume | 1.25M |
| Shares Outstanding | 185.28M |
| % Held by Institutions | 43.08 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |